Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  selenium
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-7 of 7 for your search:
Start Over
Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000602239, UZG-CUL-UHG-Non-InvasiveBladde, EU-20870, UZG-CUL-UHG-Non-InvasiveBladderCancer, CUL-UHG-Non-Invasive Bladder Cancer, NCT00729287
S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000
Phase: Phase III
Type: Natural history/Epidemiology
Status: Active
Age: 55 and over (50 and over for African Americans)
Sponsor: NCI, Other
Protocol IDs: CDR0000617778, S0000B, U10CA037429, R01EY014418, SWOG-S0000B, NCT00784225
Oral Selenium Therapy for the Prevention of Mucositis
Phase: Phase II, Phase I
Type: Supportive care
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: HORCSCT-9001, NCT01432873
Dietary Intervention in Follicular Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Dietary intervention FL, NCT00455416
Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance
Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-0580-B, NCT00744549
Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-0604-CE, NCT00844792
Colon Cancer Prevention Using Selenium
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 50 and over
Sponsor: Other
Protocol IDs: 2008-1122, NCT01211561
Start Over